Milestone Scientific, Inc. (MLSS): Price and Financial Metrics
MLSS Price/Volume Stats
Current price | $0.69 | 52-week high | $1.35 |
Prev. close | $0.70 | 52-week low | $0.52 |
Day low | $0.67 | Volume | 75,200 |
Day high | $0.76 | Avg. volume | 78,043 |
50-day MA | $0.66 | Dividend yield | N/A |
200-day MA | $0.86 | Market Cap | 48.85M |
MLSS Stock Price Chart Interactive Chart >
MLSS Stock Summary
- MLSS has a higher market value than just 14.45% of US stocks; more precisely, its current market capitalization is $49,733,769.
- The ratio of debt to operating expenses for MILESTONE SCIENTIFIC INC is higher than it is for about just 7.6% of US stocks.
- With a year-over-year growth in debt of -18.87%, MILESTONE SCIENTIFIC INC's debt growth rate surpasses merely 17.2% of about US stocks.
- If you're looking for stocks that are quantitatively similar to MILESTONE SCIENTIFIC INC, a group of peers worth examining would be HNST, ZOM, SIBN, CDXC, and SPWR.
- Visit MLSS's SEC page to see the company's official filings. To visit the company's web site, go to www.milestonescientific.com.
MLSS Valuation Summary
- MLSS's price/earnings ratio is -7; this is 124.01% lower than that of the median Healthcare stock.
- Over the past 243 months, MLSS's price/sales ratio has gone down 1.2.
Below are key valuation metrics over time for MLSS.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
MLSS | 2023-12-29 | 5.0 | 6.8 | -7.0 | -6.7 |
MLSS | 2023-12-28 | 4.8 | 6.4 | -6.7 | -6.4 |
MLSS | 2023-12-27 | 4.6 | 6.2 | -6.4 | -6.1 |
MLSS | 2023-12-26 | 4.3 | 5.8 | -6.0 | -5.7 |
MLSS | 2023-12-22 | 4.3 | 5.8 | -6.1 | -5.7 |
MLSS | 2023-12-21 | 4.3 | 5.8 | -6.0 | -5.7 |
MLSS Growth Metrics
- Its 5 year cash and equivalents growth rate is now at -73.96%.
- Its 5 year net income to common stockholders growth rate is now at -50.8%.
- Its year over year revenue growth rate is now at 53.89%.
The table below shows MLSS's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 9.411002 | -3.221857 | -7.85378 |
2022-06-30 | 9.303536 | -4.135996 | -7.925184 |
2022-03-31 | 10.08091 | -4.557275 | -7.747171 |
2021-12-31 | 10.30471 | -4.017581 | -6.818317 |
2021-09-30 | 9.670744 | -6.376852 | -6.776149 |
2021-06-30 | 8.808621 | -6.556074 | -6.223931 |
MLSS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MLSS has a Quality Grade of C, ranking ahead of 36.73% of graded US stocks.
- MLSS's asset turnover comes in at 0.423 -- ranking 112th of 186 Medical Equipment stocks.
- TNDM, TFX, and PEN are the stocks whose asset turnover ratios are most correlated with MLSS.
The table below shows MLSS's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.423 | 0.616 | -2.177 |
2021-03-31 | 0.315 | 0.637 | -2.538 |
2020-12-31 | 0.325 | 0.666 | -3.651 |
2020-09-30 | 0.411 | 0.683 | -7.765 |
2020-06-30 | 0.616 | 0.698 | 30.088 |
2020-03-31 | 1.274 | 0.690 | 6.927 |
Milestone Scientific, Inc. (MLSS) Company Bio
Milestone Scientific Inc. operates as a medical technology company. The Company manufactures, markets, and sells computer-controlled local anesthetic delivery systems for plastic surgery, podiatry, dermatology, and orthopedics. Milestone Scientific serves medical sector worldwide.
Latest MLSS News From Around the Web
Below are the latest news stories about MILESTONE SCIENTIFIC INC that investors may wish to consider to help them evaluate MLSS as an investment opportunity.
Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common StockROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000 shares of its common stock at a public offering price of $0.63 per share (the “Offering”). Gross proceeds before deducting underwriting discounts, commissions and other Offering expenses were approximately |
Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common StockROSELAND, N.J., Dec. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the pricing of an underwritten public offering of 4,765,000 shares of its common stock at a price of $0.63 per share (the “Offering”). Gross proceeds before underwriting discounts and commissions and estimated Offering expenses are expected to be approximately $3.0 million. The Offering |
Milestone Scientific announces proposed public offering of common stockMore on Milestone Scientific |
Milestone Scientific Inc. Announces Proposed Public Offering of Common StockROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced an underwritten public offering of shares of its common stock (the “Offering”). The Company also expects to grant to the underwriters a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the Offering on the same terms and con |
Milestone Scientific Commences Sales of CompuFlo® Disposables for Use in Neurostimulation Spinal Cord Implantation ProceduresAdoption of the technology at UTMB Health Clear Lake Campus Hospital follows successful evaluation process in these procedures—reporting 100% success CompuFlo helps minimize intraoperative cerebral fluid leakageand trauma to underlying nerve roots ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported it has commenced commercial sales of Com |
MLSS Price Returns
1-mo | 1.47% |
3-mo | 14.85% |
6-mo | -29.23% |
1-year | -22.99% |
3-year | -82.96% |
5-year | 81.10% |
YTD | 0.01% |
2023 | 43.73% |
2022 | -76.70% |
2021 | -2.83% |
2020 | 52.52% |
2019 | 318.67% |
Continue Researching MLSS
Want to do more research on Milestone Scientific Inc's stock and its price? Try the links below:Milestone Scientific Inc (MLSS) Stock Price | Nasdaq
Milestone Scientific Inc (MLSS) Stock Quote, History and News - Yahoo Finance
Milestone Scientific Inc (MLSS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...